In this video interview, Jeff Sidell, PhD, chief technology officer, Advarra, highlights how integration can simplify processes.
In a recent video interview with Applied Clinical Trials, Jeff Sidell, PhD, chief technology officer, Advarra, discussed current challenges in clinical research technology. He highlighted the overabundance of systems and emphasized the need for integration to streamline processes and reduce administrative overhead. Sidell also discussed the potential of AI, particularly predictive analytics, to automate repetitive tasks, enhancing efficiency and quality.
A transcript of Sidell’s conversation with ACT can be found below.
ACT: How can stakeholders address some of the technology overload industry is currently experiencing?
Sidell: One simple answer is integration. I've been in technology for long enough that I've seen when there's an integration play, so we're going integrate all these systems together, and you'll only have to log on once, and you only have to enter data once, and it's a good idea, but there's always a struggle, whose integration are you going to use? It's sort of like, who's going to be the first among equals? I still think it's possible. I think that, Advarra, for example, is in a good position to because we start at the very beginning of a clinical trial, when a protocol document is submitted to the IRB (institutional review board), all the way through to the conduct of the trial at the sites. Just like everybody else, we're going to make a play to be the integration provider. I think we're a little farther along than some of the other solution providers, but it's going to be a horse race.